Surviving Pneumonia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Community-acquired Pneumonia
- Sponsor
- Nordsjaellands Hospital
- Enrollment
- 2500
- Locations
- 1
- Primary Endpoint
- Number of death from any causes
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
The study aims to explore risk factors for poor prognosis among patients admitted with community-acquired pneumonia (CAP). During a 5-year study period, all patients (aged ≥ 18 years) admitted with CAP at North Zealand Hospital will be invited for inclusion. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at admission, daily during admission, at discharge and at follow-up. The main clinical outcomes of the study consist of deaths and development of diabetes.
Investigators
Birgitte Lindegaard Madsen
Associated professor, MD, PhD
Nordsjaellands Hospital
Eligibility Criteria
Inclusion Criteria
- •Infiltrate on chest radiograph plus one or more of the following:
- •Fever (temperature, ≥38.0°C)
- •Hypothermia (\<35.0°C),
- •New cough with or without sputum production
- •Pleuritic chest pain
- •Altered breath sounds on auscultation.
Exclusion Criteria
- •Patients unable to give informed consent
- •Patients unwilling to give informed consent
Outcomes
Primary Outcomes
Number of death from any causes
Time Frame: From date of admission until the day of death from any causes, up to 24 months
Assessed through patient files
Number of participants who develop diabetes
Time Frame: Up to 24 months
Assessed through patient files and the national registers
Secondary Outcomes
- Oral glucose tolerance test(Day 1, discharge (an average of 5 days), 1 month and 6-month)
- Number of participants who are readmitted(Up to 6 months)
- Length of hospital stay(Participants will be followed for the duration of hospital stay, an expected average of 5 days)